Trial Profile
Effects of rosuvastatin with or without ezetimibe on clinical outcomes in patients undergoing elective vascular surgery.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 02 Dec 2015
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary) ; Rosuvastatin
- Indications Angina pectoris; Cardiovascular disorders; Myocardial infarction; Stroke
- Focus Therapeutic Use
- 12 Apr 2013 New trial record
- 01 Jan 2013 Primary endpoint 'Cardiovascular-event-rate' has been met.